HomeProductsBuilding BlocksCarbocyclic ScaffoldsCyclopropanesLevobetaxolol
Chemical structure of CAS 93221-48-8

Levobetaxolol

CAS No.93221-48-8
MDL No.N/A
MFC18H29NO3
MW307.40
InChI KeyNWIUTZDMDHAVTP-KRWDZBQOSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

(S)-Betaxolol is the (S)-enantiomer of betaxolol, corresponding to the (R)-enantiomer.

CAS No.93221-48-8
Product NameLevobetaxolol

Biological Targets

ADRB1

Associated Conditions

glaucoma·ocular hypertension
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Efficacy of brinzolamide and levobetaxolol in pediatric glaucomas: a randomized clinical trial.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus • Vol. 12, Issue 3 • 2008
PMID: 18289898DOI: 10.1016/j.jaapos.2007.11.004

Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension.

Clinical ophthalmology (Auckland, N.Z.) • Vol. 1, Issue 2 • 2007
PMID: 19668496PMC: PMC2704505

Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma.

Brain research bulletin • Vol. 62, Issue 6 • 2004
PMID: 15036567DOI: 10.1016/S0361-9230(03)00070-4

Binding affinities of ocular hypotensive beta-blockers levobetaxolol, levobunolol, and timolol at endogenous guinea pig beta-adrenoceptors.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics • Vol. 20, Issue 2 • 2004
PMID: 15117564DOI: 10.1089/108076804773710759

Documentation

Similar Products